CIK: 0001609251 · Show all filings
Period: Q3 2016 (← Previous) (Next →)
Filing Date: Nov 14, 2016
Total Value ($000): $276,731 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| UTHR | UNITED THERAPEUTICS CORP | 275,764 | $32,562 | 11.8% | $136.10 | -11.7% | COM | 91307C102 |
| OM2 | ORTHOFIX INTERNATIONAL NV | 639,851 | $27,366 | 9.9% | $32.01 | — | COM | N6748L102 |
| ENTA | ENANTA PHARMACEUTICALS INC | 999,741 | $26,603 | 9.6% | $36.29 | -36.0% | COM | 29251M106 |
| — | IMPAX LABORATORIES INC | 1,032,187 | $24,463 | 8.8% | $30.42 | — | COM | 45256B101 |
| — | AMGEN INC | 126,038 | $21,024 | 7.6% | $152.19 | — | COM | 31162100 |
| — | SUCAMPO PHARMACEUTICALS CL A | 1,651,898 | $20,335 | 7.3% | $12.18 | — | COM | 864909106 |
| — | HALYARD HEALTH INC | 576,285 | $19,974 | 7.2% | $40.74 | — | COM | 40650V100 |
| — | INDIVIOR PLC | 4,736,823 | $18,829 | 6.8% | $3.34 | — | COM | G4766E108 |
| TEVA | TEVA PHARMACEUTICAL SP ADR | 397,412 | $18,285 | 6.6% | $58.35 | — | COM | 881624209 |
| MRK | MERCK & CO INC | 258,021 | $16,103 | 5.8% | $39.26 | +11.4% | COM | 58933Y105 |
| — | RTI SURGICAL INC | 4,181,091 | $13,087 | 4.7% | $4.41 | — | COM | 74975N105 |
| CNMD | CONMED CORP | 325,785 | $13,051 | 4.7% | $37.99 | +1.3% | COM | 207410101 |
| — | INVACARE CORP | 1,043,111 | $11,652 | 4.2% | $14.06 | — | COM | 461203101 |
| — | AVIRAGEN THERAPEUTICS INC | 2,713,517 | $5,210 | 1.9% | $1.40 | — | COM | 53761102 |
| — | DERMA SCIENCES INC | 884,000 | $4,128 | 1.5% | $4.57 | — | COM | 249827502 |
| — | DIGIRAD CORP | 482,121 | $2,459 | 0.9% | $4.41 | — | COM | 253827109 |
| — | JUNIPER PHARMACEUTICALS INC | 288,294 | $1,600 | 0.6% | $9.19 | — | COM | 48203L107 |